[1] |
Malhotra S, Teirstein PS. The SCRIPPS trial-catheterbased radiotherapy to inhibit coronary restenosis[J]. Invasive Cardiol, 2000, 12(6): 330-332.
|
[2] |
Ajani AE, Waksman R, Sharma AK, et al. Three-year follow-up after intracomnary gamma radiation therapy for instent restenosis. Original WRIST. Washington Radiation for In-Stent Restenosis Trial[J]. Cardiovase Radiat Med, 2001,2(4): 200-204.
|
[3] |
Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial Plus 6 months of clopidogrel (WRIST PLUS)[J]. Circulation, 2001,103(19): 2332-2335.
|
[4] |
Waksman R, Ajani AE, Pinnow E, et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Tri-al (WRIST) 12 versus WRIST PLUS[J]. Circulation, 2002,106(7): 776-778.
|
[5] |
Moses JW, Moussa I, Leon MB, et al. Effect of catheterbased iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for instent restenosis (subanalysis of the GAMMA I Randomized Trial)[J]. Am J Cardiol. 2002. 90(3): 243-247.
|
[6] |
Lansky AJ, Dangas G, Mehran R,et al. Quantitative angiographic methods for appropriate end-point analysis, edgeeffect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation[J]. J Am Coll Cardiol, 2002, 39(2): 274-280.
|
[7] |
Krueger K, Landwehr P, Zaehringer M, et al. Endovaseular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial[J]. Radiology, 2002, 224(2): 519-528.
|
[8] |
Waksman R, Bhargava B, White L, et al. Intra-coronary beta-radiation therapy inhibits recurrence of in-stent restenosis[J]. Circulation, 2000, 101(16): 1895-1898.
|
[9] |
Raizner AE, Kaluza GL The proliferation reduction with vascular energy trial (PREVENT). Curr Control Trials[J].Cardiovase Med, 2001, 2(1): 16-19.
|
[10] |
Popma JJ. Late clinical and angiographic out-comes after the use of 90Sr/90Y radiation for the treatment of instent restenosis: results from the Sr-90 treament of angiographic restenosis (START) Tri-al.versus placebo control for the treatment of in-stent restenosis[J]. Am Coll Cardiol, 2000,36: 311-312.
|
[11] |
Suntharalingam M, Laskey W, Lansky AJ, et al. Clinical and angiographic outcomes after use of 90Sr/90Y beta radiation for the treatment of in-stent restenosis: results from the stents and radiation therapy 40(START 40) registry[J]. Int J Radiat Oncol Biol Phys, 2002, 52(4): 1075-1082.
|
[12] |
Hausleiter J, Li A, Makkar R, et al. Leakage of a liquid 188Re-filled balloon system during intracoronary brachytherapy. A case report[J]. Cardiovasc Radiat Med, 2000, 2(1): 7-10.
|
[13] |
Knapp FF Jr, Guhlke S, Beets AL, et al. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds[J]. Cardiovasc Radiat Med, 1999,1(1): 86-97.
|
[14] |
Apple M, Waksman R, Chan RC, et al. Radioactive 133-Xenon gas-filled balloon to prevent restenosis: dosimetry,efficacy, and safety considerations[J]. Circulation, 2002,106(6): 725-729.
|
[15] |
Albiero R, Nishida T, Adamian M, et al. Edge restenosis after implantation of high activity 32P radioactive beta-emitting stents[J]. Circulation, 2000, 101: 2454-2457.
|
[16] |
Albiero R, Adamian M, Kobayashi N, et al. Short-and intermediate-term results of 32P radioactive beta-emitting stent implantation in patients with coronary artery disease.The Milan dose-response study[J]. Circulation, 2000, 101: 18-26.
|
[17] |
van Der Giessen WJ, Regar E, Harteveld MS, et al."Edge Effect" of 32p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff[J].Circulation, 2001, 104(18): 2236-2241.
|
[18] |
Schiele TM, Staber L, Kantlehner R, et al. Edge effect and late thrombosis-inevitable complications of vascular brachytherapy[J]. Z Kardiol, 2002, 91(11): 869-878.
|
[19] |
Kim HS, Waksman R, Chan RC, et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis[J]. Am Coll Cardiol, 2001, 37(4): 1026-1030.
|
[20] |
Giap H. Required treatment margin for coronary endovascular braehytherapy with iridium-192 seed ribbon[J]. Cardiovase Radiat Med, 2002, 3(1): 49-55.
|
[21] |
Cheneau E, Waksman R, Yazdi H, et al. How to fix the edge effect of catheter-based radiation therapy in stented arteries[J]. Circulation, 2002, 106(17): 2271-2277.
|
[22] |
Hehrlein C. Radioactive stents: problems and potential solutions[J]. Herz, 2002, 27(1): 17-22.
|